EBELECHUKWU EKWENUGO: Open Payments
NPI 1710535398 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 27 payments from 6 companies in 2025. Trend: 2023 $336 · 2024 $738 · 2025 $606
Food & beverage: $598Education: $8
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 13 | $282 |
| Otsuka America Pharmaceutical, Inc. | 8 | $202 |
| Teva Pharmaceuticals USA, Inc. | 3 | $63 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $15 |
Products named: INVEGA SUSTENNA, REXULTI, UZEDY, ABILIFY ASIMTUFII, FANAPT, ARISTADA, ABILIFY MAINTENA.
Industry payments across TX — which companies pay providers there.
